Literature DB >> 9254151

[The validity of therapeutic utility and intrinsic value as indicators of drug prescription quality: an analysis of treatments in cases of the common cold].

P J Saturno Hernández1, J J Gascón Cánovas.   

Abstract

OBJECTIVE: To determine the validity of intrinsic value and therapeutic utility.
DESIGN: The medicines prescribed in a random sample of 50 cases of common cold from each health centre evaluated were classified according to their intrinsic value (ordinal classification using five categories) and therapeutic use (dichotomized classification based on their intrinsic value). Patients with immunodeficiency or underlying pathology (COPD, cardiopathy, diabetes) were excluded. Each of the generic and non-specific indicators were studied to determine sensitivity and specificity for detecting problems in the rational prescription of medicines.
SETTING: A representative sample from 8 primary care centres in the Murcia region.
MEASUREMENTS AND MAIN RESULTS: The operative replies curve for intrinsic value revealed that this indicator was of little use in evaluating the quality of prescription.
CONCLUSIONS: The low validity of the generic prescription indicators suggests that systems to monitor quality based on a specific focus (linking the prescription to the disease treated) should be designed.

Entities:  

Mesh:

Year:  1997        PMID: 9254151

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  2 in total

1.  [Acceptance of lot sampling: its applicability to the evaluation of the primary care services portfolio].

Authors:  J López-Picazo Ferrer
Journal:  Aten Primaria       Date:  2001-05-15       Impact factor: 1.137

2.  [Validity of an indicator of the quality of pharmacological prescription in patients with hyperlipemia].

Authors:  M Fernández San Martín; C López Bilbao; E Escortell Mayor; T Sanz Cuesta; L Fidalgo García; C Rodríguez Escolar
Journal:  Aten Primaria       Date:  2001-03-31       Impact factor: 1.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.